4th Quarter - Report

AVENUE SOLUTIONS for CUBIST PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Technical changes to Food and Drug Administration Safety and Innovation Act (PL 112-144)

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —
AMY TEJRAL —

Contacted: SENATE

Budget/Appropriations BUD

Impact of sequestration on FDA user fees

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —
AMY TEJRAL —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.